Nasta Tanić
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Drug Transport and Resistance Mechanisms
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Oncology 9
- Cancer Diagnosis and Treatment 3
- Cancer-related Molecular Pathways 2
- Cancer Cells and Metastasis 2
- Co-authors
- Nikola Tanić (14 shared papers)Zorka Milovanović (10 shared papers)Milica Nedeljković (7 shared papers)Bogomir Dimitrijević (8 shared papers)Jelena Milašin (6 shared papers)Jelena Čarkić (4 shared papers)Tatjana Dramićanin (6 shared papers)Mladen Vujošević (1 shared paper)
In The Last Decade
Nasta Tanić
27 papers receiving 347 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 63
- Oncology 77
- Otorhinolaryngology 10
- Molecular Biology 150
- Complementary and alternative medicine 12
Countries citing papers authored by Nasta Tanić
This map shows the geographic impact of Nasta Tanić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasta Tanić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasta Tanić more than expected).
Fields of papers citing papers by Nasta Tanić
This network shows the impact of papers produced by Nasta Tanić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasta Tanić. The network helps show where Nasta Tanić may publish in the future.
Co-authors
The 25 scholars most cited alongside Nasta Tanić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 46 | |
| 2 | 2012 | 37 | |
| 3 | 2021 | 33 | |
| 4 | Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines. | 2006 | 26 |
| 5 | 2018 | 26 | |
| 6 | 2005 | 24 | |
| 7 | 2015 | 15 | |
| 8 | 2022 | 14 | |
| 9 | 2017 | 14 | |
| 10 | 2013 | 12 | |
| 11 | 2014 | 10 | |
| 12 | 2017 | 10 | |
| 13 | 2024 | 10 | |
| 14 | 2009 | 9 | |
| 15 | Genomic instability in drug-resistant human melanoma cell lines detected by Alu-I-arbitrary-primed PCR. | 2003 | 9 |
| 16 | 2011 | 8 | |
| 17 | 2018 | 7 | |
| 18 | 2009 | 7 | |
| 19 | Quantification of transforming growth factor beta 1 levels in metastatic axillary lymph node tissue extracts from breast cancer patients: a new specimen source. | 2009 | 6 |
| 20 | 2022 | 5 |
About Nasta Tanić
Nasta Tanić is a scholar working on Molecular Biology, Oncology, Surgery, Pathology and Forensic Medicine and Cancer Research, having authored 28 papers that have together received 350 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer Genomics and Diagnostics (3 papers), Head and Neck Cancer Studies (3 papers), Cancer Diagnosis and Treatment (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer-related Molecular Pathways (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (63 citations), Oncology (77 citations), Otorhinolaryngology (10 citations), Molecular Biology (150 citations) and Complementary and alternative medicine (12 citations). Nasta Tanić has collaborated with scholars based in Serbia, Germany and Russia. Frequent co-authors include Nikola Tanić, Zorka Milovanović, Milica Nedeljković, Bogomir Dimitrijević, Jelena Milašin, Jelena Čarkić, Tatjana Dramićanin, Mladen Vujošević, Nadja Nikolić and Jacob Gopas. Their work appears in journals such as Life, European Journal Of Oral Sciences, Archives of Oral Biology, Cancer Biology & Therapy and Chromosoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.